- Home
- SYNX vs TXMD Comparison
SYNX vs TXMD Comparison
Compare SYNX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNX
- TXMD
- Stock Information
- Founded
- SYNX 2005
- TXMD 2008
- Country
- SYNX Israel
- TXMD United States
- Employees
- SYNX N/A
- TXMD N/A
- Industry
- SYNX
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- SYNX
- TXMD Health Care
- Exchange
- SYNX Nasdaq
- TXMD Nasdaq
- Market Cap
- SYNX 15.6M
- TXMD 13.1M
- IPO Year
- SYNX 2024
- TXMD N/A
- Fundamental
- Price
- SYNX $3.07
- TXMD $1.16
- Analyst Decision
- SYNX
- TXMD
- Analyst Count
- SYNX 0
- TXMD 0
- Target Price
- SYNX N/A
- TXMD N/A
- AVG Volume (30 Days)
- SYNX 36.1K
- TXMD 18.0K
- Earning Date
- SYNX 12-31-2024
- TXMD 11-12-2024
- Dividend Yield
- SYNX N/A
- TXMD N/A
- EPS Growth
- SYNX N/A
- TXMD N/A
- EPS
- SYNX N/A
- TXMD N/A
- Revenue
- SYNX $9,893,000.00
- TXMD $1,596,000.00
- Revenue This Year
- SYNX $52.34
- TXMD $605.07
- Revenue Next Year
- SYNX N/A
- TXMD $1.11
- P/E Ratio
- SYNX N/A
- TXMD N/A
- Revenue Growth
- SYNX 18.05
- TXMD N/A
- 52 Week Low
- SYNX $2.10
- TXMD $1.10
- 52 Week High
- SYNX $4.25
- TXMD $2.75
- Technical
- Relative Strength Index (RSI)
- SYNX 52.51
- TXMD 29.78
- Support Level
- SYNX $2.74
- TXMD $1.10
- Resistance Level
- SYNX $4.25
- TXMD $1.30
- Average True Range (ATR)
- SYNX 0.44
- TXMD 0.06
- MACD
- SYNX 0.06
- TXMD -0.01
- Stochastic Oscillator
- SYNX 32.18
- TXMD 21.21
About SYNX Silynxcom Ltd.
Silynxcom Ltd is engaged in developing, manufacturing, marketing and selling ruggedized Personal Headset Devices as well as other communications accessories, all of which have been battlefield-tested and combat-proven. It specializes in developing the In-Ear Headset device, a subsegment of the Personal Headset Device market. The In-Ear Headset device is used in both in training and operations by the military, law enforcement, and disaster recovery industry professionals. It also develops, market and sell push-to-talk devices, communication controllers, and communication device cables and connectors.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.